Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Find Industry reports, Company profilesReportLinker                                                                       ...
Nächste SlideShare
Wird geladen in …5
×

World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control

311 Aufrufe

Veröffentlicht am

A comprehensive update of the 2005 edition Examines the market for addiction pharmacotherapies currently estimated at US$2 billionThe substance dependence field is transforming into a high-growth market opportunity. Supported by the success of Pfizer's recently launched Chantix/Champix, which is on track for blockbuster status in the smoking cessation sector, pharmacotherapies in development for alcohol, narcotic, and nicotine dependencies are poised to radically change the addiction treatment landscape in this difficult-to-treat patient population.The report estimates that the current market for addiction disorders is valued at US$3.2 billion and this is forecast to increase 19% to US$3.8 billion by 2016.The World Market for Addiction Disorders, 2009 2016: Future Therapies for Substance Dependence and Impulse Control, will introduce the reader a specialty pharmaceutical market which is positioned for high-growth based on analysis of marketed and pipeline drugs, company activities, and addiction disorder demographics.Therapy area forecasting and illustrative comparative sales data is presented to gain insight into leading products with sales estimates to 2016.Objectives of ReportThe objectives of this 80 page report are to provide an in-depth analysis of the global addiction pharmacotherapeutic market. Included in this study are analyses of key therapy areas, R&D programs, and innovating companies and products. The reader will benefit from market forecasts, pooled knowledge of recent industrial activities and events, and from analytical discourse, which is intended to stimulate growth and create new market opportunities.Report Highlights Include:' The current market for addiction disorders is valued at US$3.2 billion, up from US$2 billion in 2005' Critical analysis of alcohol, cocaine, opiate, and nicotine addictions' Review of epidemiological, aetiological, and demographic data for addiction disorders' Analysis of over 10 key marketed products and inclusion of 34 R&D candidates identified in preclinical to clinical stages of development for addiction disorders' Sales estimates (US$) to 2012 for major therapy areas' Strategic insights for life-cycle optimization and product development' Critical evaluation of leading addiction pharmacotherapies' Emerging markets identified and sector analysis' Trend analysis of industry events and activities over past 2 years' Detailed R&D themes and clusters by addiction area' Data generation on sector and market values between 2004 and 2012 and therapy forecasts by 2020 (US$)' High revenue-yielding prospects identified with projected sales estimations' R&D pipeline positioning for novel candidates' Market insights for product development and drug promotionWhat you can learn from this report:' Which addiction therapies are the current and potential future market leaders' How companies are reformulating products for addiction indications' Which premarket addiction pharmacotherapies are identified as high-value products' Which companies are developing drugs for addiction disorders' Sales predictions to 2016 for addiction pharmacotherapies' What the likely impact of pipeline products will be on value growth of the addiction market over the 10 years' Which addiction subsectors could be niche market opportunities' What the future outlook holds for addiction pharmacotherapies' Insight into R&D trends for alcohol, cocaine, opiate, and nicotine addictions' Which molecules and compounds are main R&D clusters for dependency disorders' Which of the pipeline candidates are top prospects in the addiction market over the next decade and to 2025Report Contains:' Detailed survey and analysis of the current and future global addiction disorder market' Comprehensive update on key marketed products indicated for alcohol, narcotic, and nicotine dependency disorders' Review of epidemiological, demographic, aetiological, and therapeutic data associated with addiction disorders' Market analysis and insight of key

Veröffentlicht in: Wirtschaft & Finanzen, Business
  • Als Erste(r) kommentieren

  • Gehören Sie zu den Ersten, denen das gefällt!

World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control

  1. 1. Find Industry reports, Company profilesReportLinker and Market Statistics >> Get this Report Now by email!World Market for Addiction Disorders, 2009 - 2016: The FutureTherapies for Substance Dependence and Impulse ControlPublished on October 2009 Report SummaryA comprehensive update of the 2005 editionExamines the market for addiction pharmacotherapies currently estimated at US$2 billionThe substance dependence field is transforming into a high-growth market opportunity. Supported by the success of Pfizers recentlylaunched Chantix/Champix, which is on track for blockbuster status in the smoking cessation sector, pharmacotherapies indevelopment for alcohol, narcotic, and nicotine dependencies are poised to radically change the addiction treatment landscape in thisdifficult-to-treat patient population.The report estimates that the current market for addiction disorders is valued at US$3.2 billion and this is forecast to increase 19% toUS$3.8 billion by 2016.The World Market for Addiction Disorders, 2009 2016: Future Therapies for Substance Dependence and Impulse Control, willintroduce the reader a specialty pharmaceutical market which is positioned for high-growth based on analysis of marketed andpipeline drugs, company activities, and addiction disorder demographics.Therapy area forecasting and illustrative comparative sales data is presented to gain insight into leading products with salesestimates to 2016.Objectives of ReportThe objectives of this 80 page report are to provide an in-depth analysis of the global addiction pharmacotherapeutic market. Includedin this study are analyses of key therapy areas, R&D programs, and innovating companies and products. The reader will benefit frommarket forecasts, pooled knowledge of recent industrial activities and events, and from analytical discourse, which is intended tostimulate growth and create new market opportunities.Report Highlights Include:The current market for addiction disorders is valued at US$3.2 billion, up from US$2 billion in 2005Critical analysis of alcohol, cocaine, opiate, and nicotine addictionsReview of epidemiological, aetiological, and demographic data for addiction disordersAnalysis of over 10 key marketed products and inclusion of 34 R&D candidates identified in preclinical to clinical stages ofdevelopment for addiction disordersSales estimates (US$) to 2012 for major therapy areasStrategic insights for life-cycle optimization and product developmentCritical evaluation of leading addiction pharmacotherapiesEmerging markets identified and sector analysisTrend analysis of industry events and activities over past 2 yearsDetailed R&D themes and clusters by addiction areaData generation on sector and market values between 2004 and 2012 and therapy forecasts by 2020 (US$)High revenue-yielding prospects identified with projected sales estimationsR&D pipeline positioning for novel candidatesMarket insights for product development and drug promotionWorld Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 1/5
  2. 2. Find Industry reports, Company profilesReportLinker and Market StatisticsWhat you can learn from this report:Which addiction therapies are the current and potential future market leadersHow companies are reformulating products for addiction indicationsWhich premarket addiction pharmacotherapies are identified as high-value productsWhich companies are developing drugs for addiction disordersSales predictions to 2016 for addiction pharmacotherapiesWhat the likely impact of pipeline products will be on value growth of the addiction market over the 10 yearsWhich addiction subsectors could be niche market opportunitiesWhat the future outlook holds for addiction pharmacotherapiesInsight into R&D trends for alcohol, cocaine, opiate, and nicotine addictionsWhich molecules and compounds are main R&D clusters for dependency disordersWhich of the pipeline candidates are top prospects in the addiction market over the next decade and to 2025Report Contains:Detailed survey and analysis of the current and future global addiction disorder marketComprehensive update on key marketed products indicated for alcohol, narcotic, and nicotine dependency disordersReview of epidemiological, demographic, aetiological, and therapeutic data associated with addiction disordersMarket analysis and insight of key addiction pharmacotherapies and pipelinesMarket value predictions of individual marketed products to 2016Insight and trend analysis of pipeline products for addiction disordersReview of promising pipeline products and potential market opportunitiesExtensive coverage of the R&D pipeline for addiction disordersGuide to leads for potential licensing opportunitiesCompanies Mentioned in this Report includeAcrux Alkermes Biotie Therapies Brookwood Pharmaceuticals Catalyst Pharma Partners Celtic Pharmaceuticals CephalonDrug Abuse Sciences Elbion Eli Lilly Forest Laboratories GlaxoSmithKline Impax Laboratories InterveXion Therapeutics J&JJanssen-Cilag Krele Pharma Merck Serono Nabi Biopharmaceuticals Pfizer Sanofi-Aventis Somaxon Pharma. STADASynosia Therapeutics Targacept Teva Pharmaceuticals Titan Pharmaceuticals WorldMeds Yaupon Therapeutics Table of ContentChapter 1. Introduction to Addiction Disorders Addiction: Substance Characteristics and Prevalence of Misuse Neurobiological Basisof Addiction Prevalence of Substance Misuse - Estimates for North America, Europe and Asia North America United States CanadaEurope Asia (Japan) Incidence Estimates for Addiction Disorders in North America, Europe, and Japan Treatment OptionsChapter 2. The Addiction Pharmacotherapy Market Market Overview for Addiction Disorders Market Forecasts by Therapeutic AreaAlcohol Addiction Narcotic Addiction Tobacco Addiction Chapter 3. Alcohol Addiction Market Alcohol Addiction Acamprosate(Campral) - Merck Serono/Forest Laboratories Disulfiram (Antabuse) - Alpharma Naltrexone Hydrochloride Alkermes - ReformulatedNaltrexone (Vivitrol) Pipeline Focus for Alcohol Addiction - Biotie Therapies Corp Nalmefene Naltrexone Depot Alcohol Addiction- Market Insights and Future Considerations Chapter 4. The Narcotic Addiction Market Global Narcotics - Usage Statistics NarcoticAddiction - The Scale of the Problem Pharmacotherapies for Narcotic Addiction - Market Evaluation Opioid AddictionPharmacotherapies Drug Substitute Therapies Subutex/Suboxone (Buprenorphine) - Schering-Plough/Reckitt Benckiser SuboxoneReformulation Methadone Drugs to Control Opioid Withdrawal Symptoms BritLofex (Lofexidine); Opizone (Naltrexone) - BritanniaPharma/STADA Naltrexone Nalorex - Bristol-Myers Squibb Opizone - Britannia Therapeutic Switching in Addiction Markets Outlookfor Pharmacotherapeutic Markets Related to Alcohol and Narcotic Abuse Chapter 5. Tobacco Addiction Prevalence and MortalityStatistics Nicotine: Mechanism of Action Tobacco Dependence and Smoking Cessation Smoking and Health ConsequencesWorld Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 2/5
  3. 3. Find Industry reports, Company profilesReportLinker and Market StatisticsHealthcare Costs of Smoking Addiction Tobacco Addiction Pharmacotherapeutics Market Analysis of Smoking CessationPharmacotherapeutics Nicotine Replacement Therapies Nicorette/Nicotrol - McNeil Healthcare/Johnson & Johnson Sales EstimatesNiQuitin/NicoDerm/Nicorette/Nicabate - GlaxoSmithKline Sales Estimates Nicotinell/Habitrol - Novartis Sales EstimatesNeuromodulating Pharmacotherapies for Smoking Cessation Zyban (Bupropion) - GlaxoSmithKline Sales Estimates Champix/Chantix(Varenicline) - Pfizer Sales Estimates Tobacco Addiction - Market Insights and Future Considerations Chapter 6. Drugs inResearch and Development Addiction Disorders - Research and Development Overview Pipeline Addiction PharmacotherapiesAlcohol Dependence Cocaine Dependence Novel Late-Stage Candidates Celtic Pharmaceuticals Synosia Therapeutics/RocheCannabis Dependence Immunotherapy Focus - InterveXion Therapeutics Opioid Dependence Late-Stage Development Productsfor Opioid Dependence Impulse Control Disorders Pipeline Focus - Gambling Addiction Tobacco/Nicotine Dependence PipelineFocus on Immunotherapies for Tobacco Dependence Nabi Biopharmaceuticals - NicVAX Celtic Pharmaceuticals - TA-NICSmoking Cessation - A Transforming Market Chapter 7. Market Analysis, Therapy Forecasting, and Prospect Mining MarketAnalysis and Therapy Forecasting Therapy Area Forecasts Comparative Analysis: Addiction Pharmacotherapies Prospect MiningAddiction Disorder Pharmacotherapy Prospects Therapy Area Forecasts 2016 and 2025 Chapter 8. Summary and Key DataPoints on the Addiction Market Key Data Points Reference Sources List of Tables Table 1.1 Neurotransmitter Systems Associatedwith Addiction Table 1.2 Drugs of Abuse and their Associations with Neurotransmitter Systems Table 1.3 Estimated Prevalence ofSubstance Misuse in Europe, 2009 (000 users) Table 1.4 Estimated Incidence for Addiction Disorders in North America, Europe andJapan, 2009 (incidence in 000s) Table 2.1 Market Synopsis for Addiction Disorders: Current data Table 2.2 Estimated Global Sales(US$) and Annual Growth (%) of Key Drugs to Treat Addictions, 2008-2016 Table 3.1 Physiological Consequences of theDisulfiram-Alcohol Reaction Table 5.1 Estimated Sales (US$) and Annual Growth (%) of Smoking Cessation Therapies, 2008-2016Table 6.1 Drugs in Development/Trials for Alcohol Dependence, 2009 Table 6.2 Drugs in Development/Trials for CocaineDependence, 2009 Table 6.3 Drugs in Development/Trials for Cannabis Dependence, 2009 Table 6.4 Drugs in Development/Trialsfor Ampetamine and Phencyclidine Dependencies, 2009 Table 6.5 Drugs in Development/Trials for Opioid Dependence, 2009 Table6.6 Drugs in Development/Trials for Impulse Control Disorders, 2009 Table 6.7 Drugs in Development/Trials for Tobacco Addiction,2009 Table 7.1 Estimated Global Drug Market (US$m) and Growth Rate (%) for Addiction Pharmacotherapies, 2008-2016 Table 7.2Therapy Area Forecasts for the World Addiction Disorders Market, 2016 and 2025 List of Figures Figure 1.1 Estimated Prevalenceof Substance Misuse in United States, 2009 Figure 1.2 stimated Prevalence of Substance Misuse in Canada, 2009 Figure 1.3Estimated Prevalence of Substance Misuse in Europe, 2009 Figure 1.4 Estimated Prevalence of Substance Misuse in Japan, 2009Figure 2.1 Estimated Sales (US$) of Addiction Drugs Segmented by Therapeutic Area, 2008-2016 Figure 2.2 Estimated Global Sales(US$) of Leading Addiction Drugs by Therapy Area, 2009 & 2016 Figure 7.1 Comparative Analysis of Leading AddictionPharmacotherapies, 2008-2016 (US$m) Figure 7.2 Key Addiction Disorder Pharmacotherapy Prospects, 2009World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 3/5
  4. 4. Find Industry reports, Company profilesReportLinker and Market Statistics Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93 If you have any questions please visit http://www.reportlinker.com/notify/contact Order Information Please verify that the product information is correct and select the format(s) you require. World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Product Formats Please select the product formats and the quantity you require. 1 User License--USD 2 149.06 Quantity: _____ Corporate License--USD 12 439.61 Quantity: _____ Contact Information Please enter all the information below in BLOCK CAPITALS Title: Mr Mrs Dr Miss Ms Prof First Name: _____________________________ Last Name: __________________________________ Email Address: __________________________________________________________________________ Job Title: __________________________________________________________________________ Organization: __________________________________________________________________________ Address: __________________________________________________________________________ City: __________________________________________________________________________ Postal / Zip Code: __________________________________________________________________________ Country: __________________________________________________________________________ Phone Number: __________________________________________________________________________ Fax Number: __________________________________________________________________________World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 4/5
  5. 5. Find Industry reports, Company profilesReportLinker and Market Statistics Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box. Payment by credit card Card Number: ______________________________________________ Expiry Date __________ / _________ CVV Number _____________________ Card Type (ex: Visa, Amex…) _________________________________ Payment by wire transfer Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189 Payment by check UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE Customer signature:   Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93World Market for Addiction Disorders, 2009 - 2016: The Future Therapies for Substance Dependence and Impulse Control Page 5/5

×